1992
DOI: 10.1016/0361-9230(92)90226-n
|View full text |Cite
|
Sign up to set email alerts
|

Evidence for dorsal root projection to somatostatin-immunoreactive structures in laminae I–II of the spinal dorsal horn

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1994
1994
2008
2008

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 51 publications
0
7
0
Order By: Relevance
“…Wheatgerm agglutinin (WGA) exhibits high affinity binding to internal N-acetyl glucosamine residues, and low affinity binding to sialic acid (Yamamoto et al, 1981;Gallagler et al, 1985), and, like BSI-B4, has been reported to label terminals in the rat superficial dorsal horn after being injected into peripheral nerves (LaMotte et al, 1989(LaMotte et al, , 1991. Similar distributions of label are seen after injection of WGA into the skin or dorsal root ganglion (DRG) (Molander & Grant, 1985;Swett & Woolf, 1985;Lu & Ho, 1991). As the detailed laminar distribution of the structures labelled by BSI-B4 and WGA has not been fully described, we have compared the distributions of label that result from injection of these two tracers into the sciatic nerve of adult.…”
Section: Introductionmentioning
confidence: 62%
See 1 more Smart Citation
“…Wheatgerm agglutinin (WGA) exhibits high affinity binding to internal N-acetyl glucosamine residues, and low affinity binding to sialic acid (Yamamoto et al, 1981;Gallagler et al, 1985), and, like BSI-B4, has been reported to label terminals in the rat superficial dorsal horn after being injected into peripheral nerves (LaMotte et al, 1989(LaMotte et al, , 1991. Similar distributions of label are seen after injection of WGA into the skin or dorsal root ganglion (DRG) (Molander & Grant, 1985;Swett & Woolf, 1985;Lu & Ho, 1991). As the detailed laminar distribution of the structures labelled by BSI-B4 and WGA has not been fully described, we have compared the distributions of label that result from injection of these two tracers into the sciatic nerve of adult.…”
Section: Introductionmentioning
confidence: 62%
“…It is possible that the absence of any transsynaptic reaction product in our EM studies is due to the relatively weak labelling intensity achieved with BSI-B4-HRP compared to WGA-HRP results. Labelling of neurons in the superficial dorsal horn has been reported in a number of studies where WGA-HRP was injected into skin (Molander & Grant, 1985;Robertson & Arvidson, 1985), DRG (Robertson & Grant, 1985;Lu & Ho, 1991), and peripheral nerves (LaMotte et al, 1989(LaMotte et al, , 1991. The transsynaptic labelling of neurons with BSI-B4-HRP was observed not only in the superficial dorsal horn but in the deeper laminae as well.…”
Section: Transsynaptic Transportmentioning
confidence: 82%
“…Those from Dr. Ho were made in rabbit against ENK (1:7,000 dilution), SP (1:7,500 dilution), or SOM (1:7,000 dilution). These antibodies have been well characterized and used in other studies (Adli et al, 1988;Cassini et al, 1989;Lu and Ho, 1992;Reddy et al, 1990;Rosenthal and Ho, 1989). Commercially available antibodies (from Immunonuclear, Inc.) were made in rabbit against ENK, SP, or SOM (all used at 1:2,000 dilution).…”
Section: Methodsmentioning
confidence: 99%
“…The following drugs were used: GDP-β-S (guanosine 5'-O-(2-thiodiphosphate), a general inhibitor of G-proteins (1.0 mM, n = 9; Sigma, dissolved in 10% dimethylsulfoxide (DMSO) and 90% ACSF); H7 ([1-(5-isoquinolinesulfonyl)-2-methylpiperazine, HCl], a general inhibitor of protein kinases, 5.0 mM, n = 6; Sigma); NPC15437 (2,6-diamino-N-([1-oxotridecyl)-2-piperidinyl]methyl)hexanamide, an inhibitor of PKC, 10.0 mM, n = 10; Research Biochemicals); H89 (Carlton et al 1992j;Molander et al 1992;Lu and Ho 1992), an inhibitor of PKA (0.01 mM, n = 9; Calbiochem). ACSF (n = 9) was used as a control.…”
Section: Administration Of Drugsmentioning
confidence: 99%